Mavyret 100-40 MG tablet 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FG2UB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,069
Award facts
- Contract value 100% obligated
- $19,068.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MAVYRET 100-40 mg tablets (84 count) valued at $19,068.70 under a firm fixed price contract. The award, issued on December 30, 2025, with an ultimate completion date of December 31, 2025, represents a non-competitive delivery against the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with performance of this delivery order taking place at its corporate office location in Pennsylvania.
This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (SPE2DX) running through December 2026, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare systems globally. MAVYRET, a hepatitis C treatment medication, represents one of the specialized pharmaceutical products the company provides through its federal contract portfolio. The delivery order demonstrates AmerisourceBergen's ongoing role as a primary vendor for the Defense Health Agency and other government healthcare systems, supporting military medical readiness through the DLA's Medical Supply Chain operations.
Quick answers
Who was awarded contract SPE2DR26FG2UB?
SPE2DR26FG2UB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FG2UB worth?
The government has obligated $19,069 on SPE2DR26FG2UB.
Is contract SPE2DR26FG2UB an order under another contract?
Yes. SPE2DR26FG2UB is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2UB competed?
The extent of competition for SPE2DR26FG2UB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award